Skip to main content
Premium Trial:

Request an Annual Quote

Bank Ups Affymetrix Estimates

NEW YORK (GenomeWeb News) – Investment bank Thomas Weisel Partners has increased its fourth-quarter and full-year 2009 revenue guidance for Affymetrix, two weeks before the firm is scheduled to report its results.

Analyst Peter Lawson said that the bank has increased its Q4 estimate to $83 million from its previous estimate of $82 million, slightly above analysts' consensus estimate of $82.8 million. It also lowered the firm's loss per share to $.10 from $.11, in line with the consensus estimate.

Lawson also increased the estimate for Affy's FY 2009 revenues to $335.4 million from $325 million, still short of the consensus estimate of $338.8 million, while lowering his estimated net loss per share on the firm to $.23 from $.35, versus a consensus loss per share estimate of $.14. His estimate assumes organic growth of 3.1 percent, he wrote in a research note.

The bank initiated its 2011 estimates on the firm with expected revenues of $353 million and EPS of $.03.

"We remain highly cautious on Affymetrix as they restructure their business and face fierce competition," Lawson wrote. "However, we feel short-term events could provide tailwinds for the stock."

Among those short-term events, which also were highlighted by Affy CEO Kevin King at last week's JP Morgan Healthcare Conference in San Francisco, are NIH stimulus funding, reacceleration of Genome-Wide Association Studies, and an increasing move into fast-growing, downstream target validation.

Affy is scheduled to release its fourth-quarter and full-year 2009 financial results on Feb. 3.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.